[2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].
D035843:Biomedical Research; D001774:Blood Chemical Analysis; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008660:Metabolism; D023303:Oxazolidinones; D011743:Pyrimidines; D011868:Radioisotopes; D011877:Radionuclide Imaging; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D014556:Urine
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D023303:Oxazolidinones; D011743:Pyrimidines; D011868:Radioisotopes; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; C036350:3-chloro-4,4-dimethyl-2-oxazolidinone; C030986:pyrimidine
ANTIDIABETICS; BLOOD CHEMICAL ANALYSIS; CLINICAL RESEARCH; METABOLISM; PYRIMIDINES; RADIOISOTOPE SCANNING; SULFONAMIDES; URINE
2-BENZOLSULFONAMIDO-5(BETA-METHOXY-AETHOXY)-PYRIMIDIN (GLYCODIAZIN), EINE NEUE BLUTZUCKERSENKENDE SUBSTANZ. I. DER STOFFWECHSEL VON GLYCODIAZIN BEIM MENSCHEN.